News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Krogulski Kenneth
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 280 shares
@ $2.03, valued at
$568.4
Small acquisition of 280 shares
@ $2.12, valued at
$593.6
Small acquisition of 280 shares
@ $2.14, valued at
$599.2
Small acquisition of 280 shares
@ $2.28, valued at
$638.4
Small acquisition of 280 shares
@ $2.29, valued at
$641.2
Small acquisition of 280 shares
@ $2.24, valued at
$627.2
Small acquisition of 280 shares
@ $2.07, valued at
$579.6
Small acquisition of 280 shares
@ $1.98, valued at
$554.4
Small acquisition of 280 shares
@ $1.96, valued at
$548.8
Small acquisition of 280 shares
@ $1.9, valued at
$532 |
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 105 shares
@ $2.57, valued at
$269.9
Bought 105 shares
@ $2.52, valued at
$264.6
Bought 105 shares
@ $2.51, valued at
$263.6
Bought 105 shares
@ $2.61, valued at
$274.1
Bought 105 shares
@ $2.54, valued at
$266.7
Bought 105 shares
@ $2.61, valued at
$274.1
Bought 105 shares
@ $2.58, valued at
$270.9
Bought 105 shares
@ $2.65, valued at
$278.3
Bought 105 shares
@ $2.66, valued at
$279.3
Bought 105 shares
@ $2.53, valued at
$265.7
Bought 105 shares
@ $2.48, valued at
$260.4 |
|
| 09/30/2022 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 110 shares
@ $2.35, valued at
$258.5
Bought 110 shares
@ $2.31, valued at
$254.1
Bought 110 shares
@ $2.23, valued at
$245.3
Bought 110 shares
@ $2.35, valued at
$258.5
Bought 110 shares
@ $2.51, valued at
$276.1
Bought 110 shares
@ $2.59, valued at
$284.9
Bought 110 shares
@ $2.59, valued at
$284.9
Bought 110 shares
@ $2.62, valued at
$288.2
Bought 110 shares
@ $2.55, valued at
$280.5
Bought 115 shares
@ $2.44, valued at
$280.6
Bought 115 shares
@ $2.38, valued at
$273.7 |
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 75 shares
@ $4.14, valued at
$310.5
Bought 75 shares
@ $3.84, valued at
$288
Bought 75 shares
@ $4.47, valued at
$335.3
Bought 75 shares
@ $4.46, valued at
$334.5
Bought 75 shares
@ $5.61, valued at
$420.8
Bought 75 shares
@ $6.15, valued at
$461.3
Bought 75 shares
@ $5.81, valued at
$435.8
Bought 75 shares
@ $4.82, valued at
$361.5
Bought 200 shares
@ $4.36, valued at
$872
Bought 200 shares
@ $4.28, valued at
$856
Bought 200 shares
@ $4.29, valued at
$858 |
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2021 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 85 shares
@ $2.69, valued at
$228.7
Bought 85 shares
@ $2.87, valued at
$244
Bought 85 shares
@ $2.82, valued at
$239.7
Bought 85 shares
@ $2.76, valued at
$234.6
Bought 85 shares
@ $2.76, valued at
$234.6
Bought 85 shares
@ $2.84, valued at
$241.4
Bought 85 shares
@ $2.73, valued at
$232.1
Bought 85 shares
@ $2.71, valued at
$230.4
Bought 85 shares
@ $2.71, valued at
$230.4
Bought 85 shares
@ $2.81, valued at
$238.9
Bought 85 shares
@ $2.76, valued at
$234.6 |
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2021 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 85 shares
@ $2.94, valued at
$249.9
Granted 85 shares
@ $2.93, valued at
$249.1
Granted 85 shares
@ $2.94, valued at
$249.9
Granted 85 shares
@ $2.89, valued at
$245.7
Granted 85 shares
@ $2.81, valued at
$238.9
Granted 85 shares
@ $2.93, valued at
$249.1
Granted 85 shares
@ $2.94, valued at
$249.9
Granted 85 shares
@ $2.99, valued at
$254.2
Granted 85 shares
@ $3.14, valued at
$266.9
Granted 85 shares
@ $3.25, valued at
$276.3
Granted 85 shares
@ $3.18, valued at
$270.3 |
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $3.56, valued at
$3.6k
|
|
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2019 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 65 shares
@ $5.87, valued at
$381.6
Bought 65 shares
@ $5.86, valued at
$380.9
Bought 65 shares
@ $5.87, valued at
$381.6
Bought 65 shares
@ $5.83, valued at
$379
Bought 65 shares
@ $5.94, valued at
$386.1
Bought 130 shares
@ $6.15, valued at
$799.5
Bought 65 shares
@ $6.17, valued at
$401.1
Bought 65 shares
@ $6.07, valued at
$394.6
Bought 130 shares
@ $6.02, valued at
$782.6
Bought 65 shares
@ $5.91, valued at
$384.2
Bought 65 shares
@ $5.78, valued at
$375.7 |
|
| 07/26/2019 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 65 shares
@ $6.42, valued at
$417.3
Bought 65 shares
@ $6.37, valued at
$414.1
Bought 65 shares
@ $6.32, valued at
$410.8
Bought 65 shares
@ $6.35, valued at
$412.8
Bought 65 shares
@ $6.34, valued at
$412.1
Bought 65 shares
@ $6.32, valued at
$410.8
Bought 65 shares
@ $6.33, valued at
$411.5
Bought 65 shares
@ $6.53, valued at
$424.5
Bought 65 shares
@ $6.55, valued at
$425.8
Bought 65 shares
@ $6.53, valued at
$424.5
Bought 65 shares
@ $6.47, valued at
$420.6 |
|
| 06/14/2019 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 116 shares
@ $6.3, valued at
$730.8
Bought 108 shares
@ $6.18, valued at
$667.4
Bought 43 shares
@ $6.02, valued at
$258.9
Bought 30 shares
@ $6.12, valued at
$183.6
Bought 20 shares
@ $6.2, valued at
$124
Bought 36 shares
@ $6.22, valued at
$223.9
Bought 97 shares
@ $5.57, valued at
$540.3
Bought 56 shares
@ $6.26, valued at
$350.6
Bought 25 shares
@ $6.05, valued at
$151.3
Bought 72 shares
@ $6.33, valued at
$455.8
Bought 76 shares
@ $5.99, valued at
$455.2 |
|
| 04/12/2019 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 382 shares
@ $5.99, valued at
$2.3k
Bought 580 shares
@ $6.12, valued at
$3.5k
Bought 80 shares
@ $6, valued at
$480
Bought 241 shares
@ $6.19, valued at
$1.5k
Bought 183 shares
@ $6.32, valued at
$1.2k
Bought 65 shares
@ $5.98, valued at
$388.7
Bought 65 shares
@ $6.4, valued at
$416 |
|
| 03/22/2019 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $5.98, valued at
$6k
|
|
| 11/24/2017 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 3,300 shares
@ $7.55, valued at
$24.9k
|
|
| 04/07/2017 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $6.45, valued at
$6.5k
|
|
| 03/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|